SCHEMBL2840047

SCHEMBL2840047

O=C(O)NC(CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5112339 0.84 — —
SCHEMBL6331659 0.84 THRB (0.32) —
SCHEMBL17764072 0.84 — —
SCHEMBL18341229 0.84 — —
SCHEMBL18340970 0.84 — —
SCHEMBL15859369 0.84 — —
SCHEMBL20186670 0.84 — —
SCHEMBL22346866 0.84 — —
SCHEMBL22346865 0.84 — —
SCHEMBL6326530 0.84 THRB (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609888-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF Metacrine, Inc. (US) 2020-02-19 — — EP claimed
WO-2018170182-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF METACRINE, INC. (US) 2018-09-20 — — WO claimed
EP-1854792-B1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-12-26 — — EP claimed
US-20090030195-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-01-29 — — US claimed
CN-101160303-A 1- (2H) -isoquinolone derivatives CHUGAI PHARMACEUTICAL CO LTD (JP) 2008-04-09 — — CN claimed
EP-1854792-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-11-14 — — EP claimed
US-4090844-A IMPREGNATION WITH POLYFUNCTIONAL CROSSLINKING COMPOUND HAVING A METHYLOL GROUP, A ZINC ACRYLATE AND A PERSULFATE INITIATOR THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1978-05-23 — — US claimed
EP-4370157-A1 ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2024-05-22 — — EP disclosed
WO-2024098039-A2 POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
US-11963960-B2 Compounds for treating or inhibiting recurrence of acute myeloid leukemia FLASH THERAPEUTICS, LLC (US) 2024-04-23 — — US disclosed
US-20240083869-A1 ISOINDOLINONE COMPOUNDS MONTE ROSA THERAPEUTICS AG (CH) 2024-03-14 — — US disclosed
US-11912682-B2 Isoindolinone compounds MONTE ROSA THERAPEUTICS, INC. (US) 2024-02-27 — — US disclosed
US-20240000964-A1 COMPOUND OR SALT THEREOF, AND ANTIBODY OBTAINED BY USING THE SAME AJINOMOTO CO., INC. (JP) 2024-01-04 — — US disclosed
EP-0000024-A1 Polyadducts containing phosphorus and their application in the flameproofing of textile materials HOECHST AKTIENGESELLSCHAFT (DE) 1978-12-20 — — EP disclosed
US-4096208-A FIREPROOFING AGENTS HOECHST AKTIENGESELLSCHAFT (DT) 1978-06-20 — — US disclosed
US-4072776-A PHOSPHOROUS CONTAINING ACRYLIC ACID ESTERS HOECHST AKTIENGESELLSCHAFT (DT) 1978-02-07 — — US disclosed
US-4052158-A CATALYTIC FREE RADICAL POLYMERIZATION, CURING STAUFFER CHEMICAL COMPANY (US) 1977-10-04 — — US disclosed
US-4024099-A High-molecular weight acidic polymers THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1977-05-17 — — US disclosed
US-3956243-A TETRAKIS-(HYDROXYMETHYL)-PHOSPHONIUM COMPOUND OR DERIVATIVE CIBA-GEIGY CORPORATION (US) 1976-05-11 — — US disclosed
US-3932560-A High-molecular weight acidic polymers THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1976-01-13 — — US disclosed
Send feedback